Over the past few decades, polymerase chain reaction (PCR) molecular diagnostics has gradually established itself as one of the most critical laboratory tools. Advancements in PCR & real-time PCR molecular diagnostics are largely driven by minor changes to enzymes and large-scale changes in a particular result. At present, considerable research and development activities are being carried out to improve the reliability and accuracy of PCR & real-time PCR molecular diagnostics– a factor that is expected to bolster the market growth during the forecast period.
The outbreak of the novel COVID-19 pandemic is expected to play an imperative role in accelerating the growth of the global PCR & real-time PCR molecular diagnostics market, as PCR & real-time diagnostics is highly critical to detect virus in individuals who exhibit no symptoms or signs of disease. In addition, the adoption of PCR & real-time PCR molecular diagnostics is on the rise for the identification and detection of Pseudomonas aeruginosa. This is likely to boost the overall prospects of the global PCR & real-time PCR molecular diagnostics market during the assessment period.
The increasing collaborations between private scientific laboratories and research institutes is projected to build a solid foundation for the PCR & real-time PCR molecular diagnostics market.
At the back of these factors, along with consistent advancements in technology and virus detection techniques, the global PCR & real-time PCR molecular diagnostics market is expected to surpass US$ 6.5 Bn mark by the end of 2030.
At present, the various techniques deployed across the molecular biology and medical diagnostics space are highly time-consuming and labor-intensive due to which, researchers and medical experts continue to focus on the discovery of time-efficient, reliable, and effective medical diagnostics. The PCR & real-time PCR molecular diagnostics has garnered considerable popularity over the past couple of decades, as it enables multiplication of a target DNA molecule due to which, the diagnosis of a range of diseases with a higher accuracy was made possible. This factor is anticipated to drive the PCR & real-time PCR molecular diagnostics market during the assessment period.
Researchers and stakeholders involved in the current PCR & real-time PCR molecular diagnostics market are of the opinion that quantitative PCR & real-time PCR molecular diagnostics is a highly robust and reliable medical diagnostics technique. Moreover, PCR & real-time PCR molecular diagnostics have a lower risk of cross-contamination, as it is predominantly carried out in automated thermal cyclers. Moreover, investments for PCR & real-time PCR molecular diagnostics have witnessed consistent growth over the past decade. Moreover, as per current observations, the trend is set to continue in the upcoming decade, due to the tremendous scope of PCR & real-time PCR molecular diagnostics in the near future.
The outbreak of the novel COVID-19 pandemic is expected to boost to the overall growth of the global PCR & real-time PCR molecular diagnostics market. Several established international organizations, including IAEA and Food and Agriculture Organization (FAO) are increasingly offering their support and expertise to various nations to facilitate the adoption of real-time reverse transcription- PCR & real-time PCR molecular diagnostics– one of the most reliable and accurate laboratory techniques used to track, detect, and assess the novel COVID-19 coronavirus strain.
The demand for PCR & real-time PCR molecular diagnostics has witnessed noteworthy growth in 2020, as governments of various nations around the world are increasingly offering monetary and policy-driven support to players involved in the PCR & real-time PCR molecular diagnostics market. In comparison with the alternative virus isolation techniques, PCR & real-time PCR molecular diagnostics has a lower risk of cross-contamination and is notably faster. This is expected to drive the demand for PCR & real-time PCR molecular diagnostics during COVID-19.
Analysts’ Viewpoint
The global PCR & real-time PCR molecular diagnostics market is expected to expand at a moderate CAGR of ~4% during the forecast period. The market growth is primarily driven by factors such as advancements in technology, progress made by quantitative PCR & real-time PCR molecular diagnostics techniques, benefits over other virus isolation and detection techniques, and growing emphasis on improving the reliability of end-results of PCR molecular diagnostics. The demand for PCR & real-time PCR molecular diagnostics has witnessed tremendous growth in 2020, due to the onset of the COVID-19 pandemic. Furthermore, as per current trends, the adoption is likely to gain momentum, as governments around the world continue to take drastic measures to curb the transmission of the COVID-19 virus.
PCR and Real-time PCR Molecular Diagnostics Market – Segmentation
|
Technology |
|
|
Product |
|
|
Application |
|
|
End User |
|
|
Region |
|
The global PCR & Real-time PCR molecular diagnostics market was worth US$ 4.1 Bn and is projected to reach a value of US$ 6.5 Bn by the end of 2030
PCR & Real-time PCR molecular diagnostics market is anticipated to grow at a CAGR of 4% during the forecast period
North America accounted for a major share of the global PCR & Real-time PCR molecular diagnostics market
PCR & Real-time PCR molecular diagnostics market is driven bt rise in prevalence of cancer and infectious diseases is projected to drive the market during the forecast period
Key players in the global PCR & Real-time PCR molecular diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd , QIAGEN N.V., Hologic, Inc., GRIFOLS, S.A., Genomic Health, and Seegene, Inc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global PCR & Real-time PCR Molecular Diagnostics Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast, 2018–2030
5. Market Outlook
5.1. Technology Advancement
5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis
6. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology
6.1. Introduction & Definition
6.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
6.2.1. Traditional PCR
6.2.2. Real-time PCR
6.2.3. Digital PCR
6.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology
7. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product
7.1. Introduction & Definition
7.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
7.2.1. Instruments
7.2.2. Reagents
7.2.3. Consumables
7.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product
8. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application
8.1. Introduction & Definition
8.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
8.2.1. Infectious Diseases Testing
8.2.1.1. HCV & HBV
8.2.1.2. Sexually Transmitted Infections
8.2.1.3. Hospital Acquired Infection
8.2.1.4. Respiratory Infections
8.2.1.5. Others
8.2.2. Oncology Testing
8.2.3. Genetic Testing
8.2.4. Others
8.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application
9. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user
9.1. Introduction & Definition
9.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
9.2.1. Hospitals
9.2.2. Diagnostic Laboratories
9.2.3. Academic & Research Centers
9.2.4. Others
9.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user
10. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region
10.1. Introduction
10.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Region, 2018–2030
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Region
11. North America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
11.2.1. Traditional PCR
11.2.2. Real-time PCR
11.2.3. Digital PCR
11.3. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
11.3.1. Instruments
11.3.2. Reagents
11.3.3. Consumables
11.4. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
11.4.1. Infectious Diseases Testing
11.4.1.1. HCV & HBV
11.4.1.2. Sexually Transmitted Infections
11.4.1.3. Hospital Acquired Infection
11.4.1.4. Respiratory Infections
11.4.1.5. Others
11.4.2. Oncology Testing
11.4.3. Genetic Testing
11.4.4. Others
11.5. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
11.5.1. Hospitals
11.5.2. Diagnostic Laboratories
11.5.3. Academic & Research Centers
11.6. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7. North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
11.7.1. By Technology
11.7.2. By Product
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
12.2.1. Traditional PCR
12.2.2. Real-time PCR
12.2.3. Digital PCR
12.3. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
12.3.1. Instruments
12.3.2. Reagents
12.3.3. Consumables
12.4. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
12.4.1. Infectious Diseases Testing
12.4.1.1. HCV & HBV
12.4.1.2. Sexually Transmitted Infections
12.4.1.3. Hospital Acquired Infection
12.4.1.4. Respiratory Infections
12.4.1.5. Others
12.4.2. Oncology Testing
12.4.3. Genetic Testing
12.4.4. Others
12.5. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
12.5.1. Hospitals
12.5.2. Diagnostic Laboratories
12.5.3. Academic & Research Centers
12.6. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
12.7.1. By Technology
12.7.2. By Product
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
13.2.1. Traditional PCR
13.2.2. Real-time PCR
13.2.3. Digital PCR
13.3. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
13.3.1. Instruments
13.3.2. Reagents
13.3.3. Consumables
13.4. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
13.4.1. Infectious Diseases Testing
13.4.1.1. HCV & HBV
13.4.1.2. Sexually Transmitted Infections
13.4.1.3. Hospital Acquired Infection
13.4.1.4. Respiratory Infections
13.4.1.5. Others
13.4.2. Oncology Testing
13.4.3. Genetic Testing
13.4.4. Others
13.5. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
13.5.1. Hospitals
13.5.2. Diagnostic Laboratories
13.5.3. Academic & Research Centers
13.6. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
13.7.1. By Technology
13.7.2. By Product
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
14.1. Introduction
14.2. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
14.2.1. Traditional PCR
14.2.2. Real-time PCR
14.2.3. Digital PCR
14.3. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
14.3.1. Instruments
14.3.2. Reagents
14.3.3. Consumables
14.4. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
14.4.1. Infectious Diseases Testing
14.4.1.1. HCV & HBV
14.4.1.2. Sexually Transmitted Infections
14.4.1.3. Hospital Acquired Infection
14.4.1.4. Respiratory Infections
14.4.1.5. Others
14.4.2. Oncology Testing
14.4.3. Genetic Testing
14.4.4. Others
14.5. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
14.5.1. Hospitals
14.5.2. Diagnostic Laboratories
14.5.3. Academic & Research Centers
14.6. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
14.7.1. By Technology
14.7.2. By Product
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
15.2.1. Traditional PCR
15.2.2. Real-time PCR
15.2.3. Digital PCR
15.3. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
15.3.1. Instruments
15.3.2. Reagents
15.3.3. Consumables
15.4. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
15.4.1. Infectious Diseases Testing
15.4.1.1. HCV & HBV
15.4.1.2. Sexually Transmitted Infections
15.4.1.3. Hospital Acquired Infection
15.4.1.4. Respiratory Infections
15.4.1.5. Others
15.4.2. Oncology Testing
15.4.3. Genetic Testing
15.4.4. Others
15.5. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
15.5.1. Hospitals
15.5.2. Diagnostic Laboratories
15.5.3. Academic & Research Centers
15.6. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
15.7.1. By Technology
15.7.2. By Product
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Global PCR & Real-time PCR Molecular Diagnostics Market Position Analysis, by Company, 2019
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Description
16.3.1.2. Business Overview
16.3.1.3. Financial Overview
16.3.1.4. Strategic Overview
16.3.1.5. SWOT Analysis
16.3.2. Elekta AB Bio-Rad Laboratories, Inc.
16.3.2.1. Company Description
16.3.2.2. Business Overview
16.3.2.3. Financial Overview
16.3.2.4. Strategic Overview
16.3.2.5. SWOT Analysis
16.3.3. bioMérieux SA
16.3.3.1. Company Description
16.3.3.2. Business Overview
16.3.3.3. Financial Overview
16.3.3.4. Strategic Overview
16.3.3.5. SWOT Analysis
16.3.4. Danaher Corporation
16.3.4.1. Company Description
16.3.4.2. Business Overview
16.3.4.3. Strategic Overview
16.3.4.4. Financial Overview
16.3.4.5. SWOT Analysis
16.3.5. Thermo Fisher Scientific, Inc.
16.3.5.1. Company Description
16.3.5.2. Business Overview
16.3.5.3. Strategic Overview
16.3.5.4. Financial Overview
16.3.5.5. SWOT Analysis
16.3.6. Becton, Dickinson and Company
16.3.6.1. Company Description
16.3.6.2. Business Overview
16.3.6.3. Strategic Overview
16.3.6.4. Financial Overview
16.3.6.5. SWOT Analysis
16.3.7. F. Hoffmann-La Roche Ltd
16.3.7.1. Company Description
16.3.7.2. Business Overview
16.3.7.3. Strategic Overview
16.3.7.4. Financial Overview
16.3.7.5. SWOT Analysis
16.3.8. QIAGEN N.V.
16.3.8.1. Company Description
16.3.8.2. Business Overview
16.3.8.3. Strategic Overview
16.3.8.4. Financial Overview
16.3.8.5. SWOT Analysis
16.3.9. Hologic, Inc.
16.3.9.1. Company Description
16.3.9.2. Business Overview
16.3.9.3. Strategic Overview
16.3.9.4. Financial Overview
16.3.9.5. SWOT Analysis
16.3.10. GRIFOLS, S.A.
16.3.10.1. Company Description
16.3.10.2. Business Overview
16.3.10.3. Strategic Overview
16.3.10.4. Financial Overview
16.3.10.5. SWOT Analysis
16.3.11. Genomic Health
16.3.11.1. Company Description
16.3.11.2. Business Overview
16.3.11.3. Strategic Overview
16.3.11.4. Financial Overview
16.3.11.5. SWOT Analysis
16.3.12. Seegene, Inc.
16.3.12.1. Company Description
16.3.12.2. Business Overview
16.3.12.3. Strategic Overview
16.3.12.4. Financial Overview
16.3.12.5. SWOT Analysis
List of Tables
Table 01 Global In-vitro Diganostics (IVD) Market for Infectious Disease, Oncology, Genetics Market Value Analysis and Forecast, 2018–2030
Table 02 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 03 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 04 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 05 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 06 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 07 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 08 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 09 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 10 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 11 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 12 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 13 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 14 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 15 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 16 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 17 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 18 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 19 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 20 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 21 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 22 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 23 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 24 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 25 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 26 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 27 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 28 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 29 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 30 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 31 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 32 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 33 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 34 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 35 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 36 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 37 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, 2018–2030
Figure 02 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share, by Technology, 2019
Figure 03 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share, by Product, 2019
Figure 04 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share, by Application, 2019
Figure 05 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share, by End-user, 2019
Figure 06 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 07 Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2019–2030
Figure 08 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Traditional PCR, 2018–2030
Figure 09 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Real-time PCR, 2018–2030
Figure 10 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Digital PCR, 2018–2030
Figure 11 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Product, 2019 and 2030
Figure 12 Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product, 2020–2030
Figure 13 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Instruments, 2018–2030
Figure 14 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Reagents, 2018–2030
Figure 15 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Consumables, 2018–2030
Figure 16 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Application, 2019 and 2030
Figure 17 Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application, 2020–2030
Figure 18 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Infectious Diseases, 2018–2030
Figure 19 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Oncology, 2018–2030
Figure 20 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Genetic Testing, 2018–2030
Figure 21 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Others, 2019 and 2030
Figure 22 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 23 Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user 2020–2030
Figure 24 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Hospitals 2018–2030
Figure 25 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Diagnostic Laboratories, 2018–2030
Figure 26 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Academic & Research Institutes, 2018–2030
Figure 27 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn), by Others, 2018–2030
Figure 28 Global PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Region, 2019 and 2030
Figure 29 Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Region, 2020–2030
Figure 30 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 31 North America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Country, 2019 and 2030
Figure 32 North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Country, 2019–2030
Figure 33 North America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 34 North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2019–2030
Figure 35 North America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Product, 2019 and 2030
Figure 36 North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product, 2020–2030
Figure 37 North America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Application, 2019 and 2030
Figure 38 North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application, 2020–2030
Figure 39 North America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 40 North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 41 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 42 Europe PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 43 Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 44 Europe PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 45 Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2019–2030
Figure 46 Europe PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Product, 2019 and 2030
Figure 47 Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product, 2020–2030
Figure 48 Europe PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Application, 2019 and 2030
Figure 49 Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application, 2020–2030
Figure 50 Europe PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 51 Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 52 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 53 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 54 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 55 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 56 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2019–2030
Figure 57 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Product, 2019 and 2030
Figure 58 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product, 2020–2030
Figure 59 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Application, 2019 and 2030
Figure 60 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application, 2020–2030
Figure 61 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 62 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 63 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 64 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 65 Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 66 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 67 Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2019–2030
Figure 68 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Product, 2019 and 2030
Figure 69 Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product, 2020–2030
Figure 70 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Application, 2019 and 2030
Figure 71 Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application, 2020–2030
Figure 72 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 73 Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 74 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 75 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 76 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 77 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 78 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2019–2030
Figure 79 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Product, 2019 and 2030
Figure 80 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product, 2020–2030
Figure 81 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by Application, 2019 and 2030
Figure 82 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application, 2020–2030
Figure 83 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 84 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 85 Global PCR & Real-time PCR Molecular Diagnostics Market Share Analysis, by Company, 2019
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
PCR & Real-time PCR Molecular Diagnostics Market Trends, 2020-2030
